Across TCGA pan-cancer cohorts, CROCCP4 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated CROCCP4 data layer.
The strongest signal is observed in uveal melanoma (UVM), where higher CROCCP4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CROCCP4 expression acts as an unfavorable survival marker, although some lineages such as BRCA and LUSC show a favorable association.
UVM, ACC, and CHOL are the cancer types where CROCCP4 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.